ClinicalTrials.gg
Drug

Carmustine clinical trials

Also written BCNU, BiCNU and FDA 0345.

studies test it
85
open now
5
in phase 3
6
first study started
1990

Counted the way a researcher would: Carmustine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Carmustine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Carmustine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
7 Mar 1977 · BICNU · NDA 017422 (FDA, Drugs@FDA)
European Union
18 Jul 2018 · Carmustine medac (previously Carmustine Obvius) · EMEA/H/C/004326 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

carmustine
77
bis-chloronitrosourea
5

Brand

BiCNU
11
GLIADEL
1

Development codes

BCNU
24
FDA 0345
2
NSC-409962
1

Studies by the year they started

83 studies that test it; most in 2000 (10)

Studies that test Carmustine, by start year
YearStudies
19901
19941
19953
19964
19972
19989
19996
200010
20011
20021
20031
20042
20053
20063
20072
20083
20091
20103
20111
20125
20132
20141
20152
20163
20171
20183
20191
20203
20212
20233

By phase

A phase 1/2 study counts in both.

Phase 1
27
Phase 2
56
Phase 3
6
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 80

Fred Hutchinson Cancer Center (7) · Memorial Sloan Kettering Cancer Center (6) · City of Hope Medical Center (6) · Duke University (6) · National Cancer Institute (NCI) (5) · Radiation Therapy Oncology Group (4) · Washington University School of Medicine (4) · Alliance for Clinical Trials in Oncology (3)

Often tested with

Tested in the same studies.

Etoposide (40) · Cytarabine (31) · Melphalan (29) · Cyclophosphamide (22) · O(6)-benzylguanine (13) · Temozolomide (7) · Filgrastim (6) · Rituximab (4)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Carmustine is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 4

Studies that test Carmustine.

Studies

Open first, then newest update. How each study uses Carmustine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 85

See all 85 studies that test Carmustine →

Given beside what is tested · 61 — Carmustine is usual care or a partner of the new treatment

Showing 20 of 61.

As the comparator · 6 — what is tested is compared with Carmustine

Codes

What other systems call Carmustine · ClinicalTrials.gg INT007154

  • MeSH (NLM) D002330CarmustineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) U68WG3173YCARMUSTINEConfirmed FDA, NLM, Wikidata
  • RxNorm 2105Confirmed FDA, Wikidata
  • Wikidata Q415869carmustineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C349CarmustineOne source FDA
  • DrugBank DB00262One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.